RenX Enterprises Corp.: director Melton Christopher received 8,254 shares

What happened

• Melton Christopher, a director, received a grant/award of derivative securities covering 8,254 shares on Oct 13, 2026. The filing reports an acquisition at $0.00 per share for a total of $0.00 (transaction code A).

Key details

• Transaction date and price: Oct 13, 2026 at $0.00 per share.
• Filing date and report period: Filed Oct 15, 2026; period of report Oct 13, 2026.
• Shares owned after the transaction: not reported in the filing.
• Instrument type and code: derivative securities (options), transaction code A (award/grant).
• Footnote F1: the options vest pro rata on a monthly basis over six months commencing on Nov 13, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.
• No late filing flag reported in the provided filing information.

Why it may matter

• This filing reports a grant of options (an award), not an option exercise or a market sale.
• The award vests monthly over six months beginning Nov 13, 2026.
• This filing does not show why the insider traded or why the company acted.